Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nutanix Inc (NTNX) vs Sanofi SA (SNY) Price & Performance

Nutanix IncTrade
Sanofi SATrade

Price performance (Past 24H)

Key statistics

Nutanix Inc vs Sanofi SA — how do they compare? Nutanix Inc trades at $54 (market cap $14.90B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 7× Nutanix Inc's market cap, and Sanofi SA pays a 5.5% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals.

NTNXSNY
Market Cap
$14.90B$104.83B
Sector
TechnologyHealth
52-Week High
$81.12$52.34
52-Week Low
$34.41$41.33
Enterprise Value
$14.41B$121.32B
Dividend Yield
5.5%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Nutanix Inc

Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.

Read more on NTNX

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY